Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 18 de 18
Filter
1.
Am J Dermatopathol ; 43(7): 510-513, 2021 Jul 01.
Article in English | MEDLINE | ID: mdl-33156025

ABSTRACT

ABSTRACT: Cutaneous reactions surrounding abdominal stoma sites are typically irritant, allergic, infectious, traumatic or pathergic in etiology. Pemphigus, which encompasses a group of vesiculobullous autoimmune skin disorders, is seldom encountered as a peristomal dermatosis. Direct immunofluorescence (DIF) studies of pemphigus generally show continuous intercellular net-like depositions of IgG. However, punctate or dot-like intercellular deposition of IgG can also be seen in cases of pemphigus. The punctuate pattern is underreported in the literature and little is known about its implication. We describe a case of a 58-year-old Caucasian man with a history of bowel obstruction, status postcolostomy, who presented with a sharply demarcated, erythematous, crusted plaque surrounding his abdominal stoma. The patient endorsed persistent pruritus. A punch biopsy of the lesion was performed for clinical suspicion of fungal infection versus irritant dermatitis. Histopathology revealed a predominantly subcorneal acantholytic dermatitis. Periodic acid-Schiff with diastase and Grocott methenamine silver histochemical stains were negative for fungi. DIF was positive for IgG and C3 detected in a punctate intercellular pattern. In conjunction with the patient's clinical presentation and DIF, a diagnosis of peristomal pemphigus foliaceous was rendered. Herein, we describe a case of punctate pemphigus presenting as a peristomal dermatosis and include a review of the literature to raise awareness of this phenomenon.


Subject(s)
Acantholysis/etiology , Colostomy/adverse effects , Pemphigus/etiology , Skin/pathology , Acantholysis/immunology , Acantholysis/pathology , Aged , Biopsy , Fluorescent Antibody Technique, Direct , Humans , Male , Pemphigus/immunology , Pemphigus/pathology , Skin/immunology
2.
Pediatr Dermatol ; 38 Suppl 2: 161-163, 2021 Nov.
Article in English | MEDLINE | ID: mdl-34047402

ABSTRACT

Language-congruent care can improve clinical outcomes. As a quality improvement initiative supported by the Department of Dermatology at Massachusetts General Hospital, the American Academy of Dermatology, and the Society for Pediatric Dermatology, our group established monthly pediatric dermatology "Spanish clinics" that scheduled Spanish-speaking patients on the same day and utilized a dedicated, live interpreter who stayed with the clinical team throughout the clinic. Patients reported high satisfaction scores, averaging 9.8 out of 10, and 90.5% of patients preferred this model to traditional appointments. Our participating physician found "Spanish clinics" allowed for more efficient care not only in the monthly pilot clinics, but in all clinics occurring during the time period.


Subject(s)
Dermatology , Language , Ambulatory Care Facilities , Child , Communication Barriers , Humans
3.
Pediatr Dermatol ; 38(4): 977-979, 2021 Jul.
Article in English | MEDLINE | ID: mdl-34101255

ABSTRACT

A virtual pediatric dermatology student-run clinic was initiated during the COVID-19 pandemic, when in-person educational opportunities were limited. The clinic's aim is to provide high-quality dermatologic care to a diverse, underserved pediatric patient population while teaching trainees how to diagnose and manage common skin conditions. In our initial eight sessions, we served 37 patients, predominantly those with skin of color, and had a low no-show rate of 9.8%. This report describes the general structure of the clinic, goals, and the patient population to provide an overview of our educational model for those interested in similar efforts.


Subject(s)
COVID-19 , Dermatology , Education, Medical , Telemedicine , Child , Dermatology/education , Humans , Pandemics , Patient Care , SARS-CoV-2 , Students
4.
J Am Acad Dermatol ; 83(5): 1274-1281, 2020 Nov.
Article in English | MEDLINE | ID: mdl-32622142

ABSTRACT

BACKGROUND: Pediatric melanoma is rare and diagnostically challenging. OBJECTIVE: To characterize clinical and histopathologic features of fatal pediatric melanomas. METHODS: Multicenter retrospective study of fatal melanoma cases in patients younger than 20 years diagnosed between 1994 and 2017. RESULTS: Of 38 cases of fatal pediatric melanoma identified, 57% presented in white patients and 19% in Hispanic patients. The average age at diagnosis was 12.7 years (range, 0.0-19.9 y), and the average age at death was 15.6 years (range, 1.2-26.2 y). Among cases with known identifiable subtypes, 50% were nodular (8/16), 31% were superficial spreading (5/16), and 19% were spitzoid melanoma (3/16). One fourth (10/38) of melanomas arose in association with congenital melanocytic nevi. LIMITATIONS: Retrospective nature, cohort size, and potential referral bias. CONCLUSIONS: Pediatric melanoma can be fatal in diverse clinical presentations, including a striking prevalence of Hispanic patients compared to adult disease, and with a range of clinical subtypes, although no fatal cases of spitzoid melanoma were diagnosed during childhood.


Subject(s)
Melanoma/diagnosis , Skin Neoplasms/diagnosis , Adolescent , Adult , Child , Child, Preschool , Female , Humans , Infant , Male , Melanoma/mortality , Retrospective Studies , Skin Neoplasms/mortality , Young Adult
5.
Pediatr Dermatol ; 37(3): 527-530, 2020 May.
Article in English | MEDLINE | ID: mdl-32065689

ABSTRACT

Little guidance on management of basal cell nevus syndrome in children exists. We report a case series of four patients diagnosed with BCNS in early childhood, in whom several highly suspicious lesions were biopsied, but several smaller and questionably concerning lesions were treated with therapies that are more tolerable for children, including topical imiquimod, 5-fluorouracil, cryotherapy, or touch electrodessication following topical anesthetic cream. These therapies were well tolerated, and all residual or persistent lesions were subsequently biopsied and found to be benign. This approach is often preferable for pediatric BCNS patients, in whom concerning lesions can be identified clinically and managed compassionately. However, any lesion that exhibits growth, bleeding, or symptoms should be biopsied for definitive diagnosis.


Subject(s)
Basal Cell Nevus Syndrome , Skin Neoplasms , Aminoquinolines , Basal Cell Nevus Syndrome/diagnosis , Basal Cell Nevus Syndrome/therapy , Child , Child, Preschool , Fluorouracil , Humans , Imiquimod , Skin Neoplasms/therapy
6.
J Pediatr ; 211: 152-158, 2019 08.
Article in English | MEDLINE | ID: mdl-31103258

ABSTRACT

OBJECTIVE: To identify risk factors associated with nonmelanoma skin cancer (NMSC) occurrence and survival in children. STUDY DESIGN: This was a multicenter, retrospective, case-control study of patients <20 years of age diagnosed with NMSC between 1995 and 2015 from 11 academic medical centers. The primary outcome measure was frequency of cases and controls with predisposing genetic conditions and/or iatrogenic exposures, including chemotherapy, radiation, systemic immunosuppression, and voriconazole. RESULTS: Of the 124 children with NMSC (40 with basal cell carcinoma, 90 with squamous cell carcinoma), 70% had at least 1 identifiable risk factor. Forty-four percent of the cases had a predisposing genetic condition or skin lesion, and 29% had 1 or more iatrogenic exposures of prolonged immunosuppression, radiation therapy, chemotherapy, and/or voriconazole use. Prolonged immunosuppression and voriconazole use were associated with squamous cell carcinoma occurrence (cases vs controls; 30% vs 0%, P = .0002, and 15% vs 0%, P = .03, respectively), and radiation therapy and chemotherapy were associated with basal cell carcinoma occurrence (both 20% vs 1%, P < .0001). Forty-eight percent of initial skin cancers had been present for >12 months prior to diagnosis and 49% of patients were diagnosed with ≥2 skin cancers. At last follow-up, 5% (6 of 124) of patients with NMSC died. Voriconazole exposure was noted in 7 cases and associated with worse 3-year overall survival (P = .001). CONCLUSIONS: NMSC in children and young adults is often associated with a predisposing condition or iatrogenic exposure. High-risk patients should be identified early to provide appropriate counseling and management.


Subject(s)
Carcinoma, Basal Cell/epidemiology , Carcinoma, Squamous Cell/epidemiology , Skin Neoplasms/epidemiology , Adolescent , Antifungal Agents/adverse effects , Antineoplastic Agents/adverse effects , Case-Control Studies , Child , Child, Preschool , Female , Genetic Predisposition to Disease/epidemiology , Humans , Immunosuppressive Agents/adverse effects , Infant , Male , Radiotherapy/adverse effects , Retrospective Studies , Risk Factors , United States/epidemiology , Voriconazole/adverse effects , Young Adult
7.
Photodermatol Photoimmunol Photomed ; 35(5): 295-303, 2019 Sep.
Article in English | MEDLINE | ID: mdl-31155747

ABSTRACT

Photodynamic therapy (PDT) utilizes a sensitizer agent and light to produce selective cell death. Dermatologists are familiar with PDT for the treatment of actinic keratoses and early nonmelanoma skin cancers, and recent studies have elucidated that PDT has resulted in improved morbidity and secondary outcomes for the treatment of various cancerous and precancerous solid tumors. Light source and dosimetry may be modified to selectively target tissue, and novel techniques such as fractionation, metronomic pulsation, continuous light delivery, and chemophototherapy are under investigation for further optimization of therapy. This article aims to review the expanding indications for PDT and demonstrate the potential of this modality to decrease morbidity and increase quality of life for patients. To illustrate these new indications, we provide a focused review of the latest literature on PDT for dermatologic and other solid tumors including gastrointestinal, peritoneal, lung, genitourinary, brain, breast, and head and neck. Data on efficacy, survival, and side effects vary across tumor types but support PDT for the treatment of numerous solid tumors. With new advances in PDT, indications for this therapeutic modality may expand.


Subject(s)
Administration, Metronomic , Neoplasms/drug therapy , Photochemotherapy , Disease-Free Survival , Humans , Neoplasms/mortality , Survival Rate
8.
Am J Dermatopathol ; 40(10): e138-e141, 2018 Oct.
Article in English | MEDLINE | ID: mdl-29742560

ABSTRACT

Keratitis-ichthyosis-deafness (KID) syndrome is a rare genodermatosis that typically results from mutations of the GJB2 gene or, less commonly, the GJB6 gene. Patients with KID syndrome are at higher risk of malignancy and infections. Here, we present 2 patients with KID syndrome who developed verrucous plaques. Given that patients with KID syndrome are at high risk of developing squamous cell carcinoma, biopsies were performed. Both cases revealed histologic findings of marked papillomatous epidermal hyperplasia with numerous fungal spores and pseudohyphae in the stratum corneum. For one case, daily oral fluconazole was initiated. The patient demonstrated dramatic resolution of his foot plaques over the course of 2 years. These cases highlight that, for the dermatopathologist, chronic fungal infection should be sought for verrucous plaques in patients with KID syndrome as, if present, this finding may alter treatment and quality of life.


Subject(s)
Candidiasis, Cutaneous/microbiology , Keratitis/complications , Skin/microbiology , Administration, Oral , Adolescent , Adult , Antifungal Agents/administration & dosage , Biopsy , Candidiasis, Cutaneous/diagnosis , Candidiasis, Cutaneous/drug therapy , Chronic Disease , Connexin 26 , Connexins/genetics , Female , Fluconazole/administration & dosage , Genetic Predisposition to Disease , Humans , Keratitis/diagnosis , Keratitis/genetics , Male , Mutation , Phenotype , Remission Induction , Skin/drug effects , Skin/pathology , Time Factors , Treatment Outcome
9.
Pediatr Dermatol ; 35(2): 234-236, 2018 Mar.
Article in English | MEDLINE | ID: mdl-29314223

ABSTRACT

A 3-year-old girl presented with a 7-month history of a waxing and waning left thigh mass associated with pruritus and erythema at the site of two previous DTaP-HepB-IPV vaccinations. Patch testing was positive to aluminum chloride, supporting a diagnosis of vaccine granuloma secondary to aluminum allergy; her symptoms had been well controlled with antihistamines and topical steroids. Injection site granulomas are a benign but potentially bothersome reaction to aluminum-containing immunizations that can be supportively managed, and we encourage strict adherence to the recommended vaccine schedule in this setting. Patch testing is a sensitive, noninvasive diagnostic tool for patients presenting with this clinical finding, and dermatologist awareness can prevent unnecessary medical examination and provide reassurance.


Subject(s)
Aluminum Compounds/adverse effects , Chlorides/adverse effects , Granuloma/etiology , Hypersensitivity, Delayed/diagnosis , Urticaria/diagnosis , Vaccination/adverse effects , Aluminum Chloride , Aluminum Compounds/immunology , Child, Preschool , Chlorides/immunology , Female , Glucocorticoids/therapeutic use , Granuloma/drug therapy , Histamine Antagonists/therapeutic use , Humans , Hypersensitivity, Delayed/drug therapy , Hypersensitivity, Delayed/etiology , Leg/pathology , Patch Tests/methods , Urticaria/drug therapy , Urticaria/etiology
10.
Pediatr Dermatol ; 35(3): 354-360, 2018 May.
Article in English | MEDLINE | ID: mdl-29569376

ABSTRACT

BACKGROUND/OBJECTIVES: Melanoma in children and adolescents is uncommon, and there are limited data on pediatric outcomes. Several studies have shown comparable survival rates in children and adults, but other research demonstrates that prepubescent children have more favorable outcomes. This study aims to compare childhood and adolescent melanoma. METHODS: Retrospective cohort study of children who received a melanoma diagnosis at the Massachusetts General Hospital between January 1, 1995, and December 21, 2016. Childhood melanoma is defined as disease occurring in patients younger than 11 years old, and adolescent melanoma is defined as disease occurring in patients 11 to 19 years old. Patients diagnosed with ocular melanoma and borderline tumors of uncertain malignant potential were excluded. This analysis compares clinical, histopathologic, and outcome characteristics of childhood and adolescent melanoma. RESULTS: Thirty-two children with melanoma were identified (12 children, 20 adolescents). The spitzoid melanoma subtype was significantly more common in children (6/12) than adolescents (2/20) (P = .01). Four adolescents and no children with melanoma died from melanoma, and survival was significantly different between the age groups (P = .04). Median follow-up time for survivors was 3.6 years. CONCLUSIONS: These results suggest that children and adolescents present with different melanoma subtypes and that adolescents have a more aggressive disease course than children.


Subject(s)
Melanoma/pathology , Skin Neoplasms/pathology , Adolescent , Age Factors , Child , Child, Preschool , Cohort Studies , Female , Humans , Male , Melanoma/mortality , Retrospective Studies , Skin Neoplasms/mortality , Survival Rate , Young Adult
12.
Dermatol Surg ; 43(11): 1371-1378, 2017 Nov.
Article in English | MEDLINE | ID: mdl-28595249

ABSTRACT

BACKGROUND: Cyanoacrylate tissue adhesives are not more likely to result in wound dehiscence or infection than sutured closures. However, suturing is the gold standard for optimal cosmetic appearance of scars. OBJECTIVE: To determine whether cyanoacrylate tissue adhesives produce a cosmetic outcome equivalent to sutures at 3 months. Secondary outcomes include time for wound closure, time spent on wound care, and surgeon and patient satisfaction. MATERIALS AND METHODS: Seventy-one patients scheduled for skin cancer excision at Beverly Hospital were included in this prospective, randomized, single-blind study. Cosmetic appearance was assessed by a masked panel of dermatologists and plastic surgeons who evaluated digital photographs. Secondary outcomes were assessed by nursing recordings and patient and surgeon evaluations. RESULTS: There was no significant difference in wound appearance (Visual Analog Scale: p = .4693, modified Hollander Wound Evaluation Score: p = .6413) between adhesives and sutures. It was faster and easier for a surgeon to use adhesives, and subjects spent less time caring for and were more satisfied by wounds sealed with adhesives than sutures. CONCLUSION: Cyanoacrylate tissue adhesives produce cosmetic outcomes that are not statistically significantly different than sutures; furthermore, they are associated with fast application, easy wound care, and patient satisfaction.


Subject(s)
Cyanoacrylates/therapeutic use , Postoperative Complications/prevention & control , Skin Neoplasms/surgery , Tissue Adhesives/therapeutic use , Wound Closure Techniques , Aged , Esthetics , Female , Humans , Male , Patient Satisfaction , Prospective Studies , Single-Blind Method , Sutures
13.
Lancet ; 388(10062): 2871, 2016 12 10.
Article in English | MEDLINE | ID: mdl-27979405
16.
JAAD Case Rep ; 4(2): 185-188, 2018 Mar.
Article in English | MEDLINE | ID: mdl-29892662

ABSTRACT

A 14-month-old boy presented with a slow-growing, asymptomatic back plaque, which was biopsied and found to have S100 positivity, sparse CD34 staining, and no significant mitotic activity, nuclear pleomorphism, or necrosis; genetic workup found LMNA-NTRK1 gene fusion, overall consistent with lipofibromatosis-like neural tumor (LPF-NT). LPF-NT is rare, with 14 cases previously reported, and our patient is the first report of this diagnosis in infancy. This case report and literature review includes comparison of similar diagnoses including lipofibromatosis, low-grade malignant peripheral nerve sheath tumor, infantile fibrosarcoma, and dermatofibrosarcoma protuberans and serves to aid detection of LPF-NT presenting in pediatric patients by highlighting similarities and differences that should prompt consideration. LPF-NT shows locally aggressive behavior only and should not be confused with conditions that have potential for distant spread. However, case reports of metastasizing LMNA-NTRK1 tumors draw into question whether growths with this gene fusion exist on a spectrum of disease severity. Our patient was treated with wide local excision and has developed no complications or evidence of recurrence with 6 months of follow-up time.

SELECTION OF CITATIONS
SEARCH DETAIL